Download a fully functional 30-day trial version of either StatXact® - the most widely used exact statistics software or LogXact® for small-sample logistic regression.
East® Surv is the premier survival study design tool that reduces typical trial duration, subjects and costs in oncology, cardiovascular and infectious disease studies, including HIV and hepatitis.
Time-to-event endpoints present a particularly challenge for clinical trial designers. Rather than determining power on a fixed sample size, power depends on the number and distribution of events among the treatment arms during the trial's course. Typical clinical study complications – subject drop-outs, treatment cross-over, uncertain control arm event rates – are difficult to fully grasp without capable design and simulation tools.
Simple assumptions are simply inadequate – they don’t account for variable enrollment rates, non-constant hazard functions or variable differential drop-outs.
Cytel’s East® Surv option for East® enables superior survival study designs with superior methods to address complex parameter assumptions. EastSurv helps trials designers make the toughest design decisions with confidence by accounting for:

East® Surv features powerful yet simple to use simulation tools. Specify data generating parameters easily and intuitively to have East® Surv simulate complex survival data, then saved for further analysis. Then, at each interim look and the final look, East® Surv provides fixed sample size and group sequential hypothesis testing, as well as Monte Carlo averages of follow-up time, plus cumulative accruals, events and drop-outs in each treatment group.
Please contact us to better understand how East® Surv would help your team improve survival study designs, along with licensing and training options.